3,4-methylenedioxyamphetamine and Attention Deficit Disorder with Hyperactivity

3,4-methylenedioxyamphetamine has been researched along with Attention Deficit Disorder with Hyperactivity in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Attention Deficit Disorder with Hyperactivity: A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)

Research

Studies (1)

Authors

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Attention Deficit Disorder with Hyperactivity